Psychotherapeutic drugs: how to minimise complications of therapy.
D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D003692:Delayed-Action Preparations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006331:Heart Diseases; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000145:classification; D009626:Terminology as Topic
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D008996:Monoamine Oxidase Inhibitors; D011619:Psychotropic Drugs; D001569:Benzodiazepines